- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | Shuttle Pharmaceuticals Holdings, Inc. - S-1, General form for registration of securities | - | SEC Filings | ||
| 30.07. | Shuttle Pharmaceuticals Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 25.06. | Shuttle Pharmaceuticals Holdings, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 24.06. | Shuttle Pharmaceuticals Holdings, Inc.: Shuttle Pharmaceuticals Announces Closing of $4.25 Million Private Placement Priced At-the-Market | 2 | GlobeNewswire (USA) | ||
| SHUTTLE PHARMACEUTICALS Aktie jetzt für 0€ handeln | |||||
| 20.06. | Shuttle Pharmaceuticals raises $4.25 million in private placement | 1 | Investing.com | ||
| 20.06. | Shuttle Pharmaceuticals sammelt 4,25 Millionen US-Dollar durch Privatplatzierung ein | 3 | Investing.com Deutsch | ||
| 20.06. | Shuttle Pharmaceuticals Holdings, Inc.: Shuttle Pharmaceuticals Announces Pricing of $4.25 Million Private Placement Priced At-the-Market | 2 | GlobeNewswire (USA) | ||
| 12.06. | Shuttle Pharmaceuticals plant Aktienzusammenlegung im Verhältnis 25:1 | 2 | Investing.com Deutsch | ||
| 12.06. | Shuttle Pharmaceuticals Holdings, Inc.: Shuttle Pharma Announces Proposed Reverse Stock Split as Part of Strategic Nasdaq Compliance Initiative | 157 | GlobeNewswire (Europe) | GAITHERSBURG, Md., June 12, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) ("Shuttle Pharma" or the "Company"), a discovery and development stage specialty pharmaceutical... ► Artikel lesen | |
| 04.06. | Shuttle Pharma ernennt neuen Vorstandsvorsitzenden | 2 | Investing.com Deutsch | ||
| 04.06. | Shuttle Pharma appoints new Chairman to its Board | 3 | Investing.com | ||
| 04.06. | Shuttle Pharmaceuticals Holdings, Inc.: Shuttle Pharma Appoints George Scorsis Chairman of the Board of Directors | 1 | GlobeNewswire (USA) | ||
| 15.05. | Shuttle Pharmaceuticals Holdings, Inc.: Shuttle Pharma Provides Corporate Update | 276 | GlobeNewswire (Europe) | GAITHERSBURG, Md., May 15, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) ("Shuttle Pharma" or the "Company"), a discovery and development stage specialty pharmaceutical... ► Artikel lesen | |
| 15.05. | Shuttle Pharmaceuticals Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 08.05. | Shuttle Pharmaceuticals Holdings, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 08.05. | Shuttle Pharma erreicht Halbzeitmarke bei Glioblastom-Studie | 3 | Investing.com Deutsch | ||
| 21.04. | Shuttle Pharmaceuticals Holdings, Inc.: Shuttle Pharma to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025 | 1 | GlobeNewswire (USA) | ||
| 10.04. | Shuttle Pharma reicht Patent für Krebsbehandlungsinnovation ein | 8 | Investing.com Deutsch | ||
| 10.04. | Shuttle Pharma files patent for cancer treatment innovation | 2 | Investing.com | ||
| 10.04. | Shuttle Pharmaceuticals Holdings, Inc.: Shuttle Pharma Developing Pretreatment Diagnostic Blood Tests for Prostate Cancer, Files Provisional Patent for PSMA Ligand Conjugates to Treat Prostate Cancer | 119 | GlobeNewswire (Europe) | Filing provisional patent application with the USPTO entitled "PSMA-Targeted PARP Inhibitor conjugates for Precision Cancer Therapy" key to advancement of Diagnostic and Therapeutic programs Dr. Alan... ► Artikel lesen |
1 2 3 Weiter >>
48 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| INNOCAN PHARMA | 0,128 | -1,54 % | Innocan Pharma Aktie: BRUTALE PROGNOSE zwingt Anleger zum Handeln. So sollten Sie HEUTE reagieren! | ||
| ARZNEIWERK AG VIDA | 0,270 | 0,00 % | EQS-HV: Arzneiwerk AG VIDA: Bekanntmachung der Einberufung zur Hauptversammlung am 04.09.2025 in Berlin mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG | EQS-News: Arzneiwerk AG VIDA
/ Bekanntmachung der Einberufung zur Hauptversammlung
Arzneiwerk AG VIDA: Bekanntmachung der Einberufung zur Hauptversammlung am 04.09.2025 in Berlin... ► Artikel lesen | |
| CRESCO LABS | 0,615 | -2,61 % | Cresco Labs Inc. Q2 Loss Narrows | ||
| CSPC PHARMA | 1,120 | +1,59 % | CLSA: CSPC PHARMA Stock Price Weak but Fundamentals Strong; Biz Development Progress in line | ||
| TONIX PHARMACEUTICALS | 40,200 | +0,50 % | Pre-market Movers: Creative Global Technology, Liminatus Pharma, CureVac, Jupiter Neurosciences, Tonix Pharmaceuticals | BEIJING (dpa-AFX) - The following are some of the stocks making big moves in Thursday's pre-market trading (as of 08.05 A.M. ET).In the Green Creative Global Technology Holdings Limited (CGTL)... ► Artikel lesen | |
| AMARIN | 12,600 | -1,56 % | Amarin Corporation plc: Amarin Reports Second Quarter 2025 Financial Results | -- European Partnership with Recordati Established to Maximize VAZKEPA® in Europe; Global Corporate Restructuring Implemented with Anticipated $70 Million in Operating Expense Savings Over Next 12... ► Artikel lesen | |
| NEKTAR THERAPEUTICS | 19,700 | -0,51 % | Nektar Therapeutics Reports Second Quarter 2025 Financial Results | SAN FRANCISCO, Aug. 7, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the second quarter ended June 30, 2025.
Cash... ► Artikel lesen | |
| JAGUAR HEALTH | 2,190 | +4,29 % | Jaguar Health, Inc.: Enrollment Initiated in Jaguar Health Study of its FDA Conditionally Approved Canalevia-CA1 Prescription Drug for Dogs | Company strategy: In discussions with multiple potential animal health company partners to collaborate to bring Canalevia®, conditionally approved for CID, to regulatory approval and commercialization... ► Artikel lesen | |
| XORTX THERAPEUTICS | 0,650 | -3,27 % | XORTX Therapeutics Inc (3): XORTX Therapeutics closes $114,500 (U.S.) financing | ||
| NUMINUS WELLNESS | 0,027 | -100,00 % | Numinus Wellness Inc. Announces First Quarter Fiscal 2025 Results | Vancouver, British Columbia--(Newsfile Corp. - August 8, 2025) - Numinus Wellness Inc. (TSX: NUMI) (OTCQB: NUMIF) (FSE: LR23) ("Numinus" or the "Company"), a mental health care company focused on innovative... ► Artikel lesen | |
| CANNOVUM CANNABIS | 0,217 | -14,57 % | Cannovum Health begrüßt neuen strategischen Mehrheitsinvestor - Triple Crown Ventures wird neuer Hauptgesellschafter | Berlin (ots) - Die Cannovum Health GmbH feiert einen entscheidenden Meilenstein in ihrer Unternehmensentwicklung. Triple Crown Ventures wird neuer Mehrheitsinvestor. Mit diesem Schritt gewinnt das Unternehmen... ► Artikel lesen | |
| TALPHERA | 0,340 | -1,31 % | Talphera, Inc.: Talphera Announces First Quarter 2025 Financial Results and Provides Corporate Update | Cash and investments at March 31, 2025, as adjusted to include the proceeds from the first tranche of the private placement financing which closed on April 2, 2025... ► Artikel lesen | |
| BETTERLIFE PHARMA | 0,049 | -6,67 % | BETTERLIFE HLDG (06909): COMPLETION OF VERY SUBSTANTIAL ACQUISITIONS IN RELATION TO THE ACQUISITIONS OF (1) THE CREDITOR'S RIGHTS; (2) JIGUANG REAL ESTATE; ... | ||
| MEDIPHARM LABS | 0,040 | -4,74 % | MediPharm Labs Corp.: MediPharm Announces Voting Results from the 2025 Annual and Special Meeting of Shareholders | TORONTO, June 17, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm" or the "Company"), a pharmaceutical company specialized in precision-based cannabinoids... ► Artikel lesen | |
| VIRACTA THERAPEUTICS | 0,019 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 10.02.2025 | The following instruments on Boerse Frankfurt do have their last trading day on 10.02.2025Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 10.02.2025ISIN NameES0105015012 LAR... ► Artikel lesen |
Das Unternehmen SHUTTLE PHARMACEUTICALS HOLDINGS INC kann der Branche Pharma zugeordnet werden. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 3,500 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SHUTTLE PHARMACEUTICALS HOLDINGS INC finden Sie auf Wallstreet Online.